Articles tagged with Inflammatory Disorders
Researchers have identified larazotide acetate as a promising treatment for multi-inflammatory syndrome in children (MIS-C), a rare but severe condition. The study showed rapid improvement in symptoms and faster resolution of gastrointestinal issues among children treated with the drug, suggesting its potential as an adjuvant therapy.
Researchers at MDI Biological Laboratory discovered that age-related chronic inflammation is caused by disruption of chromatin architecture. This leads to misexpression of genes lacking CpG islands, resulting in inflammation and loss of cellular function. The findings provide a unifying theory for the age-related degenerative diseases.
A natural product from the dried root of Sophora flavescens, combined with an enzyme inhibitor, has been found to reduce neuroinflammation in a mouse model of Parkinson's disease. The compound kurarinone may provide hope for alleviating symptoms of the incurable disorder.
A preclinical study identified a protein complex critical for regulating apoptosis and necroptosis. Inhibiting this complex may help prevent excessive cell death and tissue damage associated with heart attacks, autoimmune disorders, and COVID-19. Researchers believe that targeting the PPP1R3G/PP1γ pathway could lead to new treatments f...
Researchers used identical twins to exclude genetic influences and track immune system changes responsible for triggering multiple sclerosis. The study found that an error in the communication of immune cells leads to greater activation of T cells, causing damage in the central nervous system.
A study tracking 425 patients post-COVID-19 found high prevalence of cognitive deficits, psychiatric impairments, and significant memory decline. Researchers observed no correlation between the severity of the disease or socio-economic factors with psychiatric alterations, suggesting a possible link to delayed inflammatory processes.
A new study finds that immune cells clear away a key Alzheimer's disease protein on an oscillating daily cycle controlled by circadian rhythms. The discovery provides a potential mechanism linking Alzheimer's disease to disruptions in sleep cycles and may lead to the development of chronotherapeutics.
A team led by Case Western Reserve University discovered the novel repair properties of Gasdermin B protein, promoting restoration of epithelial layers and effective wound-healing. The findings have significant implications for designing therapeutics to enhance wound repair in various organs.
A study found that severe COVID-19 is associated with endothelial dysfunction, strong inflammatory processes, and a dysfunctional immune system. The researchers discovered seven plasma proteins linked to severe disease, which are also involved in the regeneration of the endothelial barrier during recovery.
Researchers found sublingual immunotherapy with house dust mite extract to be effective in reducing signs and symptoms of atopic dermatitis. The treatment, administered over 18 months, resulted in significant improvements in pruritus and lesions, with rare side effects.
Scientists at the University of Bonn discovered the structure of the NLRP3 protein's binding site for CRID3 inhibitor, which can target inflammatory diseases like gout and Alzheimer's. The study provides a powerful therapeutic tool against chronic inflammatory diseases.
A UC Davis Health study found that taking bile acids or treatments regulating their production levels can help control psoriasis inflammation. Bile acids inhibited skin inflammation by stopping immune T cells from producing proinflammatory protein IL-17A and blocking immune cell movement to the site.
Researchers at TUM discover that intestinal bacteria interact with Paneth cells in the gut mucus layer, leading to chronic inflammation. This finding may lead to new treatments for IBD.
Scientists at UC Riverside and UCLA have engineered nanoparticles to serve as 'molecular traps' that bind to SARS-CoV-2, preventing it from attacking macrophages and inducing inflammation. The findings suggest potential therapeutic strategies for treating COVID-19-associated diseases.
Four MUSC Hollings Cancer Center researchers received American Cancer Society Institutional Research Grants worth $35,000 each. The grants support promising projects that aim to push cancer care forward. Researchers are working on various innovative projects, including a digital literacy training program for community health workers an...
A study reveals a powerful subset of vascular macrophages expressing CLEC4A2 fosters 'good' macrophage behavior, limiting plaque build-up. This discovery challenges the widely held belief that macrophages only play a harmful role in cardiovascular disease.
Associate Professor Morten Arendt Rasmussen from the University of Copenhagen aims to develop a personalized dietary profile using a cohort of young people with asthma and other inflammatory diseases. The goal is to provide tailored diet recommendations that can help alleviate symptoms and improve health outcomes.
Researchers identify eleven rare genetic variants associated with eczema, accounting for over 20% of the disease's heritability. The variants are found in genes that code for proteins involved in inflammatory reactions, providing promising targets for new therapeutic approaches.
Researchers at UC Davis Health developed a new treatment that simultaneously blocks IL-6 and TNF cytokines, providing superior protection against acute graft-versus-host-disease severity and mortality. The dual-cytokine blockade approach did not impair beneficial graft-versus-tumor effects.
Researchers found that asthma causes immune cells to behave in a way that prevents brain tumor growth, suggesting a potential new therapeutic approach. The findings suggest reprogramming T cells to act like those in asthma patients could be a new treatment for brain tumors.
A recent study identified several protein biomarkers that protect against the development of inflammatory diseases such as psoriasis and osteoarthritis. The researchers used Mendelian Randomization to determine whether high levels of these proteins are associated with a lower risk of disease.
Rutgers Robert Wood Johnson Medical School is part of a $470 million RECOVER initiative studying post-acute sequelae of COVID-19 (PASC) in children. The study aims to investigate long-term effects, symptoms and treatments for PASC, such as Multisystem Inflammatory Syndrome in Children (MIS-C).
Researchers discover a unique subset of group 3 innate lymphoid cells that circulate in the bloodstream and infiltrate the brain, sparking inflammation in conditions like MS. Countering their activity could be a new therapeutic strategy for such conditions.
A recent study found that carboxymethylcellulose, a widely used food additive, alters the intestinal environment of healthy individuals by reducing beneficial bacteria and nutrients. The research suggests that long-term consumption of this additive may promote chronic inflammatory diseases, highlighting the need for further study.
A study by Tokyo University of Science researchers identifies a novel regulatory axis targeting dendritic cell activity, suppressing autoimmune disease symptoms and bone loss. They discovered DCIR binds to glycoproteins on macrophages and osteoclasts, reducing inflammation and immune responses.
A new study from Keck School of Medicine of USC shows that vaping is associated with dysregulation of mitochondrial genes and immune response genes, similar to smoking. The research found that over 80% of gene dysregulation in vapers correlated with the intensity and duration of current vaping.
Researchers found that people with ALS have higher levels of arachidonic acid, a lipid involved in inflammation, and that tampering with this pathway can reduce muscle-weakening symptoms. The study suggests that targeting the arachidonic acid pathway may offer potential new therapies for Lou Gehrig's disease.
A new study from Intermountain Healthcare found that low-frequency intermittent fasting raises galectin-3 levels, a protein tied to inflammatory response, and lowers rates of insulin resistance and metabolic syndrome. This suggests that even occasional fasting may have positive health effects.
Researchers discovered inhibiting or genetically deleting the MTHFD2 enzyme reduced disease severity in various inflammatory disease models. This suggests that MTHFD2 function is important for immune cell regulation, particularly for T cell subsets involved in inflammation.
Researchers found that albino mice with a mutated tyrosinase gene are more susceptible to non-alcoholic steatohepatitis (NASH) than black mice. This study provides new insights into the genetic factors contributing to NASH and its progression.
Researchers identified two distinct clusters of patients with Prurigo nodularis: those with increased inflammation and those with a higher likelihood of spinal disease. This study suggests that personalized treatment approaches can be tailored to specific patient profiles.
A USF Health study reveals that fibrinogen can directly interact with neurons, leading to inflammation and neurodegeneration in Alzheimer's disease and traumatic brain injury. The researchers found that blocking the binding of fibrinogen to its receptors may alleviate short-term memory problems associated with these diseases.
A new study investigates the effects of cord blood cell transplantation and curcumin administration on Tay-Sachs disease. The results show an increase in enzyme production and a decrease in inflammation after transplantation, as well as improved symptoms and reduced GM2 ganglioside levels when combined with curcumin.
Researchers have identified a link between certain gut microbiome molecules and the immune system protein P-gp, which plays a critical role in gut inflammation. The study suggests that supporting a healthy balance of microbes in the gut may help regulate P-gp expression and prevent chronic inflammation.
Researchers at Osaka University studied mice with mutations in ADAR1 and found that impaired Z-RNA recognition contributed to abnormal growth, organ development, and chronic inflammation. This study highlights the importance of proper RNA editing and its relation to Aicardi-Goutières syndrome.
Researchers at Trinity College Dublin have identified a new molecule called 4-OI that can limit the production of prostaglandins from macrophages. This discovery could lead to the development of new anti-inflammatory compounds for treating diseases such as COVID-19 and sleeping sickness.
A University of Illinois Chicago clinical trial aims to evaluate the impact of a healthy diet on asthma management in adults. Participants with uncontrolled asthma will be assigned to either an education-only group or a group receiving dietary counseling and guidance on the DASH eating plan, a diet approach proven for hypertension mana...
Researchers discovered that skin-derived T cells can migrate into the bloodstream and cause inflammation in other organs, such as the intestine. The study provides new approaches to therapy and diagnostic options for stem cell transplantation.
Researchers at UC San Diego School of Medicine report that children with multisystem inflammatory syndrome in children (MIS-C) have normal T cell responses to the COVID-19 virus, contrary to previous hypotheses. This suggests that MIS-C may not be caused by an abnormal immune response to the virus.
Researchers at Uppsala University found that allergic stimulation activates mast cell precursor cells, which can produce cytokine IL-13 contributing to asthma development. This challenges the idea that only mature immune cells are involved in immune reactions.
Researchers have found that synthetic bile acid Nor-UDCA directly affects the immune system and reduces inflammation in chronic-inflammatory liver disease. The therapy also guides misdirected CD8-T cells back onto their correct path, allowing them to resume their normal function.
The USPSTF updates its recommendation to include low-dose aspirin use, which demonstrates reduced risks of perinatal death, and is consistent with its previous 2014 recommendation. Preeclampsia affects approximately 4% of pregnancies in the US and is a serious health complication.
A study found that 73% of hospitalized COVID-19 patients developed delirium, leading to lasting cognitive impairment and increased need for skilled nursing care. The disease itself, sedatives, and inflammation can contribute to this outcome.
Researchers identified a new cell type in human skin contributing to AD and psoriasis, highlighting potential therapeutic targets. The study revealed CD14+ type 3 dendritic cells co-producing IL1B and IL23A, essential for PSO pathogenesis.
The FDA has granted orphan drug status to Octagam 10%, the first and only IVIg treatment for adult dermatomyositis. The therapy is expected to become the first treatment option for adults with this rare disease, which affects approximately 10 out of every million U.S. residents.
Researchers found that hematopoietic cell transplantation (HCT) normalizes the gut microbiota of patients with IBD associated with XIAP deficiency. The study revealed that HCT decreases gut inflammation and restores diversity in gut microbiota, improving symptoms and quality of life for affected individuals.
A multicenter randomized trial showed acupuncture improved symptoms of moderate to severe CP/CPPS, with effects lasting over 24 weeks. Acupuncture was more effective than sham therapy in reducing symptoms and improving quality of life for men with chronic prostatitis/chronic pelvic pain syndrome.
Researchers used a hamster model to study COVID-19 lung damage, discovering that the immune system's response plays a crucial role in disease progression. They found that certain cells involved in lung immunity ingest the virus, triggering an inflammatory response that can be brought under control by T cells.
Researchers identified genes and cell types involved in rare inflammatory disease MIS-C in children following COVID-19 infection. The study found that specific immune cells are downregulated and associated with a sustained inflammatory response.
Researchers at Yale University discovered a rare childhood disorder that mimics inflammatory bowel disease, revealing the underlying genetic cause of chronic inflammation. The study identified ELF4 as a crucial regulator of inflammation, suggesting its role in multiple diseases.
The study found that a single-number quantitative measure, the inflammatory-age score, tracks well with a person's immunological response and the likelihood of incurring aging-related diseases. Blood levels of CXCL9, a cytokine secreted by certain immune cells, contribute more powerfully than any other clock component to the inflammato...
A research team from POSTECH and ImmunoBiome Inc. discovered a yeast-derived polysaccharide mixture that selectively suppresses inflammatory T-cells and induces regulatory T-cells with anti-inflammatory function. The study found that MGCP, the novel polysaccharide, effectively inhibits inflammatory diseases without major side effects.
Research suggests that an imbalance in gut microbiota, or dysbiosis, may play a significant role in the progression of Hidradenitis Suppurativa. The study found reduced abundance of certain bacteria in HS patients, leading to an inflammatory response.
Researchers from Skoltech, Italy, discovered a new axis for preventing liver fibrosis by targeting the GILZ protein. The study used mice models and verified findings with human clinical data, suggesting that controlling the signaling pathway involving GILZ could lead to treating inflammatory liver diseases.
Researchers discovered that Niemann-Pick type C disease is associated with neuroinflammation and impaired intracellular lipid transport, leading to the accumulation of lipids in the brain. The findings suggest a potential new approach for monitoring disease progression and response to therapy.
Researchers at Karolinska Institutet have discovered a key role of monocytes in sarcoidosis, revealing they can be potent TNF producers and predict disease outcome. This breakthrough opens possibilities for identifying biomarkers and more effective treatment strategies, potentially reducing cases of chronic sarcoidosis.
Scientists at La Jolla Institute for Immunology have found elongated neutrophil-derived structures (ENDS) in the blood of septic patients, which break off from immune cells and change shape as they course through the body. ENDS are 100-fold more detectable in sepsis patients than healthy individuals.
A team of researchers has discovered a drug-like compound that blocks the CD14 inflammatory protein, reducing inflammation and preventing cytokine storms in laboratory tests. The compound's potential as a new treatment for inflammatory diseases, including COVID-19, is being explored in pre-clinical trials.
Researchers discovered a potential strategy to prevent life-threatening inflammation, lung damage, and organ failure in patients with COVID-19. They identified specific cytokines that trigger inflammatory cell death pathways, leading to tissue damage and multi-organ failure. Treatment using existing drugs targeting these cytokines show...
A study published in Scientific Reports reveals that prepubertal male and female rats exhibit distinct immune responses to infection, with males exhibiting a more severe inflammatory reaction. The researchers suggest that the X chromosome may play a key role in determining this difference.